20th European Headache Congress (EHC 2026)
9 December 2026 – 12 December 2026
The 20th European Headache Congress (EHC26) of the European Headache Federation takes place at hub27 in Berlin from 9 to 12 December 2026, marking the congress's 20th anniversary. Under the guiding theme "Walls Come Down", the programme spans basic science and clinical research in headache disorders, opening with research on a secondary headache disorder and drawing on real-world data and clinical expertise. The official congress language is English.
46 sessions · 4 speakers
Co-Organiser (1)
Conventus Congressmanagement & Marketing GmbH
Media Partners (3)
touchNEUROLOGY · Neuro Depesche · MGO Medizin
Sponsors (6)
Pfizer · Abbvie Inc. · Novartis · Organon Inc. · H. Lundbeck A/S · Teva Pharmaceuticals
Association Partners (4)
International Headache Society · EAN – European Academy of Neurology · Deutsche Schmerzgesellschaft e.V. · DMKG
Exhibitors (3)
Pfizer · Novartis · Teva Pharmaceuticals
Agenda
- Teaching Course 1 | Vascular Mimics of Migraine 9 December 2026 · Breakout Room 1
- Teaching Course 2 | Headache and Vertigo: Case-Based Practical Course 9 December 2026 · Breakout Room 2
- Opening Session 9 December 2026
- Teaching Course 4 | Nerve Blocks in Headache Disorders: A Hands-On Course on Interventional Approaches 10 December 2026 · Breakout Room 2
- Teaching Course 3 | How to Write a Scientific Paper 10 December 2026 · Breakout Room 1
- Teaching Course 6 | Trigeminal Autonomic Cephalalgias (TACs) and Their Mimics 11 December 2026 · Breakout Room 2
- Teaching Course 5 | Invasive and Non-Invasive Devices in Headache Therapy 11 December 2026 · Breakout Room 1
- Special Programme Track for General Practitioners – Day 1 11 December 2026
- Teaching Course 7 | Tension-Type Headache (TTH) 12 December 2026 · Breakout Room 1
- Teaching Course 8 | Migraine Outside the Headache: Prodromes and Aura 12 December 2026 · Breakout Room 2
- Special Programme Track for General Practitioners – Day 2 12 December 2026
- Ear-, Mouth- and Face Pain – The Neglected Parts of the Head?
- Environmental and Lifestyle Determinants in Headache Disorders
- From Migrainous Infarction to Stroke-Induced Migraine-Like Symptoms
- Gepants Will Make CGRP Monoclonal Antibodies Obsolete
- GLP-1 Agonists Meet Headache Medicine: A Metabolic Revolution?
- Headache Disorders: Spillover Effects on Global Development Goals Framework
- A Novel Treatment Target for Migraine
- Hormonal Therapies Are Essential in the Armamentarium of Migraine Therapy
- IHS Jes Olesen Award
- Intracranial Hypertension: From CSF Dynamics to Disease-Modifying Therapy
- Joint Symposium: EHF & EAN – Real World Data: Anti-CGRP and Combination Treatments
- Joint Symposium: EHF & EFIC
- Lifetime Achievement Award – Prof. Hans-Christoph Diener
- Medication Overuse (MO) and Medication Overuse Headache (MOH)
- New Advances in the Pathophysiology of Migraine: From the Cell to the Patient's Bedside
- New Perspectives on Menstrually-Related Migraine: From Bench to Bedside to Population
- Differentiating and Phenotyping Migraine Aura
- PACAP, TRPM and Beyond
- Placebo and Nocebo Effects in Headache Medicine
- Rare Primary Headaches
- Sex Differences in Headache Disorders
- Controversial Migraine Treatment
- Clinics and Pathophysiology of Cluster Headache – An Update
- Spontaneous Intracranial Hypotension: Expanding the Clinical Spectrum and Therapeutic Strategies
- Circadian Mechanisms in Primary Headache
- CGRP-Based Therapies Are Not the Future for Cluster Headache
- Botulinum Toxins in Headaches and Facial Pain Disorders: Evolving Mechanisms and Future Directions
- Are We Ready for Neuropeptide-Driven Migraine Diagnosis?
- Are We Ready for Anti-CGRP Therapies in Children and Adolescents?
- Are We Measuring Migraine Neuropeptides Properly?
- Are Secondary Headaches and Triggered Primary Headaches the same?
- Acute Headache Treatment
- The Phenomenology, Pathophysiology and Therapy of Migraine Before the Occurrence of Pain
- Therapeutic Approach to Primary Headache Treatment in Special Populations
- Transition and Local-Based Precision of Headache in Children and Adolescents